Crossmark

In vitro anti-cancer effects of gefitinib via EGF receptor-targeted delivery on triple-negative breast cancer cells

Published Online: 2023-07-13

Published Print: 2023-09

Authors

Ahn, Jae Won

Song, Yeong Jun

Park, Kyeongsoon https://orcid.org/0000-0002-8558-3983
Funding

Funding for this research was provided by:

The National Research Foundation of Korea (NRF-2019M3A9E2066883, NRF-2021R1A4A1022206, NRF-2023R1A2C1004940)
License Information

Text and Data Mining valid from 2023-07-13

Version of Record valid from 2023-07-13
More Information

Article History

Received: 16 February 2023

Revised: 9 May 2023

Accepted: 12 June 2023

First Online: 13 July 2023

Declarations

:

: The authors declare that they have no conflict of interest.

Document is current